{"id":"NCT01167010","sponsor":"Eurofarma Laboratorios S.A.","briefTitle":"A Non-inferiority, Comparative Study Between Foraseq®, Eurofarma´s Formoterol/Budesonide and Alenia® in Asthma","officialTitle":"A Phase III, Randomized, Non-inferiority, Open-label, Comparative Study Between Foraseq® Inhalation Capsules, Eurofarma's Single Formoterol / Budesonide Inhalation Capsule and Single Alenia® Inhalation Capsule in Asthmatic Patients","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2011-04","primaryCompletion":"2011-08","completion":"2012-02","firstPosted":"2010-07-21","resultsPosted":"2025-05-01","lastUpdate":"2025-05-01"},"enrollment":552,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"NONE","primaryPurpose":"TREATMENT"},"conditions":["Asthma"],"interventions":[{"type":"DRUG","name":"Formoterol/Budesonide","otherNames":[]},{"type":"DRUG","name":"Foraseq","otherNames":["Formoterol/Budesonide"]},{"type":"DRUG","name":"Alenia","otherNames":["Formoterol/Budesonide"]}],"arms":[{"label":"Formoterol/Budesonide","type":"EXPERIMENTAL"},{"label":"Foraseq","type":"ACTIVE_COMPARATOR"},{"label":"Alenia","type":"ACTIVE_COMPARATOR"}],"summary":"The primary objective will be to compare the Eurofarma and Alenia formulations regarding their impact on the pulmonary function of mild to moderate persistent asthma patients and the secondary objective will be to compare the three study formulations regarding the clinical control of the symptoms and the patients' compliance to the treatment.","primaryOutcome":{"measure":"Forced Expiratory Volume in 1 Second (FEV1) at the Final Visit (FV)","timeFrame":"12 weeks","effectByArm":[{"arm":"Formoterol/Budesonide","deltaMin":2.53,"sd":0.79},{"arm":"Alenia","deltaMin":2.51,"sd":0.77}],"pValues":[]},"eligibility":{"minAge":"12 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":6,"exclusionCount":8},"locations":{"siteCount":5,"countries":["Brazil"]},"refs":{"pmids":[],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":1,"n":154},"commonTop":["Left and posterior knee trauma infection"]}}